RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway

Qian Suna Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaView further author information

Junjie Xub Office of director, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, ChinaView further author information

Fan’en Yuana Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China;c Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USAView further author information

Yan Liud Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaView further author information

Qianxue Chena Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaView further author information

Lirui Guoa Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaCorrespondence[email protected]
View further author information

Huimin Donge Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaCorrespondence[email protected]
View further author information

Baohui Liua Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, ChinaCorrespondence[email protected]

https://orcid.org/0000-0001-5821-6945 View further author information

show all

RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date